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Abstract
Background: Perrault syndrome is a genetically heterogenous, very rare disease, characterized clinically by
sensorineural hearing loss, ovarian dysfunction and neurological symptoms. We present the case of a 33 years old
female patient with TWNK-associated Perrault syndrome. The TWNK gene is coding the mitochondrial protein
Twinkle and currently there are only two reports characterizing the phenotype of TWNK-associated Perrault
syndrome. None of these publications reported about special brain MRI alterations and neuropathological changes
in the muscle and peripheral nerves.
Case presentation: Our patients with TWNK-dependent Perrault syndrome had severe bilateral hypoacusis, severe
ataxia, polyneuropathy, lower limb spastic paraparesis with pyramidal signs, and gonadal dysgenesis. Psychiatric
symptoms such as depression and paranoia were present as well. Brain MRI observed progressive cerebellar
hyperintensive signs associated with cerebellar, medulla oblongata and cervical spinal cord atrophy. Light
microscopy of the muscle biopsy detected severe neurogenic lesions. COX staining was centrally reduced in many
muscle fibers. Both muscle and sural nerve electron microscopy detected slightly enlarged mitochondria with
abnormal cristae surrounded by lipid vacuoles. In the sural nerve, dystrophic axons had focally uncompacted myelin
lamellae present. Genetic investigation revealed multiple mtDNA deletion and compound heterozygous mutations
of the TWNK gene (c.1196 A > G, c.1358 G > A).
Conclusion: This study demonstrates that TWNK associated Perrault syndrome has a much broader phenotype as
originally published. The coexistence of severe hypoacusis, spastic limb weakness, ataxia, polyneuropathy, gonadal
dysgensia, hyperintense signals in the cerebellum and the presence of the mtDNA multiple deletion could indicate
the impairment of the TWNK gene. This is the first report about pyramidal tract involvement and cerebellar MRI
alteration associated with TWNK-related Perrault syndrome.
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Background
TWNK (previously C10orf2) is a gene (chromosome 10)
encoding the Twinkle protein, an adenine nucleotide-
dependent DNA helicase acting in the mitochondria,
with a focal function in the maintenance of the mtDNA
integrity [15, 11]. Mutations of TWNK are well-
described in mitochondrial DNA depletion syndrome 7
(MTDPS7) which is also known as infantile-onset spino-
cerebellar ataxia (infantile onset-SCA) [13] and auto-
somal dominant progressive external ophthalmoplegia 3
(autosomal dominant-PEO3) [6]. In 2014, a new pheno-
type Perrault syndrome was associated to TWNK gene
alterations [12]. The observations of Morino et al. were
supported by Demain [3] and Oldak [14] and now, by
our study as well.
Perrault syndrome is a very rare disease (< 1/1.000.000),
characterized by sensorineural hearing loss, ataxia and ovar-
ian dysfunction. Additional features can include a variety of
neurologic symptoms, such as nystagmus, dysarthria, and
muscle weakness. In other Twinkle-related syndromes ex-
ternal ophthalmoplegia, migraine, epilepsy, cardiomyop-
athy, cataracts, and psychiatric symptoms could further
complicate the issue as well [6, 7, 10].
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The brain MRI scans of patients with Twinkle muta-
tions show a very diverse landscape. In ad-PEO3, mild
cortical atrophy and white matter abnormalities in sub-
cortical and periventricular regions were described [14].
In mitochondrial DNA depletion syndrome 7, stroke-
like lesions and edematous lesions were described with
no predilection, and in other cases, cerebellar atrophy –
sometimes together with cerebellar white matter lesions
– were reported [4, 6]. In the TWNK-related Perrault
syndrome, cerebellar atrophy is the consistent MRI find-
ing [3]. In LARS2- and HARS2-associated Perrault syn-
drome, no data were published about the brain imaging,
while in CLPP-associated Perrault syndrome, high signal
intensity in the corticospinal tract deep white matter
could be found [8]. In HSD17B4-dependent Perrault
syndrome and in TWNK-dependent Perrault syndrome,
cerebellar atrophy was only described besides non-
specific findings [9].
In Perrault syndrome, besides the central nervous sys-
tem (CNS) symptoms, sensorimotor peripheral neur-
opathy is an important and frequent finding. Both
axonal and demyelinating forms of neuropathies have
been described by NCS (nerve conduction studies) [12].
We have one report about type II myofiber atrophy [12]
but none of the published studies investigated the
neuropathological alterations of the muscle and periph-
eral nerves in details.
The phenotypic heterogeneity of Perrault syndrome
is accompanied with genetic heterogeneity. The most
commonly affected genes are HARS2, HSD17B4,
LARS2, CLPP, ERAL1 [2, 3] and more authors re-
cently proposed SGO2 and CLDN14 [5]. Out of the
six currently known genes, HSD17B4 is involved in
peroxisomal fatty acid beta-oxidation, LARS2, HARS2,
CLPP, and the newly associated TWNK and ERAL1
play a role in mitochondrial function. TWNK muta-
tion may result in mtDNA depletion in case of mito-
chondrial DNA depletion syndrome 7, or in mtDNA
multiple deletions in Perrault syndrome and auto-
somal dominant external ophthalmoplegia 3 [6].
Here we aim to report the detailed phenotypic
(clinical, laboratory, imaging and neuropathological)
characteristics and the genetic data of our case with
Perrault syndrome caused by TWNK mutations.
Case presentation
A Hungarian patient and her family are the subject of
this report. Written informed consent was obtained
from all persons involved in the investigations. The
patient gave informed, written consent for publication
of the history and examinations. This article is a
retrospective case study; it has the approval of the
Ethical Committee of the Medical Research Council
(TUKEB 44599–2/2013/EKU 535/2013).
Detailed routine neurological and psychiatric examina-
tions were performed, and family history was taken.
Symptom Checklist-90-Revised (SCL-90-R) test was per-
formed to measure the patient’s scores on 9 primary
symptom dimensions (somatization, hostility, depression,
obsession-compulsion, interpersonal sensitivity, anxiety,
phobic anxiety, paranoid ideation and psychosis) and
also, on an additional subscale, the presence of sleep and
memory problems, which altogether provide the global
severity index (GSI). In the process of analysis, the SAS
system was used (Release 9.1 TS Level 1 M3, Statistical
Analysis System, SAS-Institute USA). The nerve conduc-
tion study was performed using standard methods (Dan-
tech Keypoint, Denmark), the median, ulnar motor and
sensory nerves, peroneal and tibial motor nerves, and
sural nerve were investigated. The patient was examined
by MRI in 2008 and 2016 (3 Tesla, Philips Achieva)
in the MR Research Center of Semmelweis University.
FLAIR, MPR, T1 and T2 weighted scans were made,
analyzed and compared. The muscle and nerve hist-
ology and histochemistry were assessed by standard
methods. Transversely oriented muscle blocks were
obtained from the quadriceps femoris muscle. Cryo-
stat sections were obtained from both the muscle and
sural nerve specimen for light microscopy, and for
glutaraldehyde-fixed and Epon-embedded material for
electron microscopic studies.
DNA was isolated from both blood and muscle. The
mtDNA deletion was detected by long range PCR. The
sequence analysis for POLG1 gene was performed by
Sanger sequencing. The sequence was compered to hu-
man reference genome (hg38) by NCBI Blast software.
HSD17D4 and HARS2 genes were analyzed at Cento-
gene. The NGS panel was developed in the Institute of
Genomic Medicine and Rare Disorders, the panel consisted
of 51 genes which were previously described to play a role
the mtDNA maintenance. Library preparation was per-
formed with SureSelect QXT kit (Agilent Technologies,
CA, USA) according to the manufacturer’s instructions.
Panel: 98191 kbp region size, 1358 probes. Sequencing:
MiSeq reagent kit v2, 300 cycles, Illumina.MiSeq platform
(Illumina, San Diego, USA) was used for the NGS run.
Analysis and variant calling was performed with SureCall
software (Agilent Technologies, CA, USA). We filtered
for known disease-causing/benign variants (HGMD,
Alamut, dbSNP, ensembl.org, PubMed, RGD, ftp.
expasy.org, DMDM databases) and for rare variants
(minor allele frequency < 0.5% in Exome Aggregation
Consortium (ExAC) and 1000Genomes (1000G), Genome
Aggregation Database (genomeAD) and Trans-Omics for
Precision Medicine (TOPMed) databases. Mutations were
filtering by prediction softwares (Polyphen2, SIFT, Muta-
tionTaster). In the analysis we followed the below listed
main steps: First, we set the following quality scores:
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GATK (QUAL) > 50, GQ> 40, RD > 4. We used the Sure-
Call software to filter the variants. The missense, non-
sense, indels and splice site variants were selected with a
MAF (minor allele frequency) of < 0.01. All SNVs with
higher score than three of SureCall were excluded. Next
filtering was performed with in silico prediction software
(Polyphen2, Mutation taster: FATHMM). The confirm-
ation and segregation analyses of the alterations were per-
formed by Sanger sequencing. Finally we used the ACMG
(American College of Medical Genetics) guideline to indi-
cate pathogenicity of the variants.
The 33-year-old female was a member of a non-
consanguineous family. She had two healthy siblings, her
father had multiple brain ischemia and died of esopha-
geal cancer, her mother was healthy. The proband’s first
symptom, progressive hypoacusis (sensorineural hearing
loss) started at the age of 4. The progressive hypoacusis
is currently very severe. The progressive gait disturbance
started at age 12. Currently, she is wheelchair-bound
due to the severe ataxia and associated lower limb weak-
ness. She often complains of myalgia and muscle
crumps. She has never had a period, the treatment with
different endocrinological medications were not success-
ful. She has few social relationships due to her querulous
and paranoid personality. Neurological examination re-
vealed bilateral horizontal (and also downbeat) nystag-
mus, severe hearing loss on both sides, moderate
dysarthria, pes cavus on both sides, moderate atrophy,
severe, predominantly proximal spastic paraparesis in
the lower limbs, increased deep tendon reflexes, and bi-
lateral pyramidal signs on both upper and lower limbs.
She had severe truncal and limb ataxia, and upper limb
dysdiadochokinesis. Slight distal type sensory deficit was
detected as well in the lower limbs. Psychiatric examin-
ation observed moderate depression, anxiety, querulous
behavior and paranoid personality traits. Her intellectual
ability was intact. SCL-90-R detected higher scores on
the hostility and somatization subscales.
The laboratory investigations detected her sex hor-
mone levels (FSH, LH, estradiol) in the postmeno-
pausal range, which is in line with primary amenorrhea:
FSH 101.04 IU/L (norm: postmenopausal: 25.8–134.8 IU/L)
LH: 49.22 IU/L (norm: postmenopausa:7.7–58.5 IU/L), es-
tradiol 5 pg/ml (norm: postmenopausal: < 10–39.2 pg/mL),
DHEA-S: 5.78 umol/L (norm: 1.65–11 umol/L). Prolactin,
progesterone end total testosterone levels were normal. Ele-
vated IGF-1 levels could be detected (1.65–11 umol/L,
norm: 50–175 ng/mL). At age 33, her serum CK, LDH, and
lactate levels were in the normal range, but previously (at
age 28), laboratory analysis observed slightly elevated CK
and lactate levels. EEG (electroencephalography) de-
tected mild cortical dysfunction. ENG (electroneuro-
graphy) observed severe mixed type neuropathy. The
histological analysis of the muscle biopsy from tibial
anterior muscle revealed signs of chronic neurogenic
atrophy (Fig. 1a, b). Oxidative enzyme reaction could
not detect any ragged red or blue fibers, COX stain-
ing was pale in the center of several muscle fibers,
but COX-negative fibers were not present. Electron
microscopy detected slightly enlarged mitochondria
with abnormal cristae in the muscle (Fig. 1d). Next to
the mitochondria, frequently lipid droplets were
attached (Fig. 1c). The sural nerve biopsy found pre-
dominantly axonal type neuropathy. Complex group
of degenerated and regenerated myelinated fibers were
observed (Fig. 2a). In one myelinated fiber, adaxonal
vacuole was present. Enlarged mitochondria were
present in the axons and in the Schwann cells as well
(Fig. 2b). In some axons, osmiophil globoids were
seen, and in some Schwann cells, pi granules were
present (Fig. 2c). In some fibers, slight signs of de-
myelinating components, such as focal myelin decom-
pactation, were observed (Fig. 2b).
The first MRI was performed at the age of 25. On the
axial images, enlarged 4th ventricle and hyperintense signs
in the cerebellum could be detected. Medulla oblongata,
cervical spinal cord, and cerebellar atrophy were also
present (Fig. 3a, b, c). The second MRI at the age of 33
showed the same alterations, and the progression of the
hyperintense signs in cerebellum and the cerebellar atro-
phy that had been previously detected (Fig. 3d, e, f).
The genetic investigation started with the establish-
ment of the patients karyotype, which is 46XX. The
investigation of the mitochondrial DNA hotspots de-
tected multiple mtDNA deletions in the muscle tissue.
The sequencing of the POLG1, HSD17B4 and HARS2
genes did not reveal any pathogenic alterations. An NGS
(next generation sequencing) panel of 51 genes (Add-
itional file 1: Table S1) responsible for the intergenomic
communication revealed a compound heterozygous muta-
tion (c.1196 A >G, (p.Asn399Ser)(rs863223921), c.1358
G >A, (Arg453Gln) in the TWNK gene (NM_021830.5).
Prediction scores provided by Annovar [1] were the fol-
lowing: c.1196A >G: Polyphen2: possibly damaging,
MutationTaster: disease-causing, FATHMM: tolerated,
c.1358G >A: Polyphen2: benign, MutationTaster: disease
causing, FATHMM: deleterious. Both rare variants could
be confirmed in the proband via Sanger sequencing. The
segregation analysis of the parents by Sanger sequencing
revealed the c.1358G > A variation in the father, the
c.1196 A >G in the mother in heterozygous form. (Fig. 4a,
b) Copy number variations in the TWNK gene were not
present. The variant frequency for both alterations are the
following: the c.1196A >G (N399S) (rs863223921) muta-
tion was found in the Genome Aggregation Database
(genomeAD) in non-Finnish European with MAF: 3.978e-
06 in the Trans-Omics for Precision Medicine (TOPMed)
database with MAF: 0.00003, while this was not present in
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Fig. 1 Neuropathological investigations. a Predominantly neurogenic alteration can be observed in the muscle tissue (large caliber variation,
angular atrophic muscle fibers) H&E staining X250. b In the semithin section, many muscle fibers contained centrally numerous small vacuoles.
Semi-thin section X350. c Electron microscopic picture of the muscle specimen. Lipid vacuoles are attached to the mitochondria. x d Enlarged
mitochondria with abnormal cristae in the muscle tissue. × 24,000
Fig. 2 Electron microscopic pictures of the sural nerve biopsy specimen. a Complex group of degenerated and regenerated myelinated fibers. In
one myelinated fiber, adaxonal vacuole is present, in another one, a myelin-like figure can be observed. × 8400. b Vesicular widening of the
myelin in the region of a Schmidt-Lanterman cleft. In the Schwann cell and in the axon, slightly enlarged mitochondria (white arrows) are
present. The myelin sheaths are slightly decompacted (dotted arrows). × 20.000 C. In a Schwann cell, a pi granula is present. × 16.000
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the 1000 Genomes Project Phase 3 (1000G), and Ex-
ome Aggregation Consortium (ExAc) databases. The
c.1358 G > A (R453Q) (rs760988188) mutation was
found in the gnomAD in non-Finnish European with
MAF 8.79e-06, in the TOPMed with MAF: 0.00001,
while this was not present in the 1000Gp3 and ExAc
databases. Both the previously published variant the
c.1196 A > G, and the novel c.1358 G > A variant de-
scribed by us are likely pathogenic based on the
ACMG guideline (both PM2, PP1, PP2, PP3, PP4).
One of her healthy siblings is carrying the c.1196A >G
mutation in heterozygous form, her mother carries the
same mutation in a heterozygous form and her father is
carrying the c.1358A >G mutation in heterozygous form.
Discussion and conclusion
Here, for the first time, we are reporting a comprehen-
sive clinical and morphological (imaging and neuro-
pathological) characterization of patient with TWNK
(Twinkle) gene associated Perrault syndrome. Besides
the classical signs of this syndrome, such as severe
hypoacusis, ovarium dysgenesis and sensorimotor neur-
opathy, severe pyramidal tract lesion was observed as
well, which was previously not reported in any of the
cases. We are also the first to report the presence of
cerebellar hyperintense lesion associated with Perrault
syndrome. Until now, there have been only four previous
reports describing mutations in TWNK gene alterations
in association with Perrault syndrome. The patient
reported in this study had compound heterozygous mu-
tations in the TWNK gene. One of the disease-causing
mutations, the c.1196A > G (Asn399Ser) variant was
already associated with Perrault syndrome by Demain in
a Caucasian family [3]. The second rare variant is a
novel, likely pathogenic variant found by our group:
c.1358G > A (Arg453Gln). There is one common clinical
finding in all of the known TWNK-dependent Perrault
syndrome patients’ ataxia and sensory neuropathy. Inter-
estingly, PEO was not a clinical feature in our case, but
it was present in three of the previously described cases.
Spastic paraparesis and pyramidal signs seem to be
unique in our patient. In the other cases, hyporeflexia or
areflexia was present. Based on our observation, TWNK-
associated Perrault syndrome could also be considered
as a rare type of spastic ataxia. Intellectual abilities
seemed intact in all reported cases, and psychiatric
symptoms are described in Perrault syndrome, but not
in the TWNK-associated form. In the case presented by
us, ovarium agenesis and uterus hypoplasia were present
with elevated LH and FSH and lower estrogen levels. In
previous studies, gonadal dysgenesis, streak ovaries were
mentioned with the indications of elevated LH and FSH
levels with low estradiol level [3]. We also detected ele-
vated IGF-1 levels. Dynamically changing serum CK and
lactate levels were observed in our patient, while in pre-
vious studies, elevated CK level was observed in two re-
lated patients, and elevated lactate level was evaluated in
one of two affected sisters.
Fig. 3 Brain MRI of the patient. a (FLAIR horizontal), b (T2 horizontal) and c (sagittal horizontal) are MRI examinations performed in 2008, while d
(FLAIR horizontal), e (T2 horizontal) and f (sagittal) was performed in 2016. The hyperintense signs (white arrows) in the cerebellum are clearly
visible on the images and show progression between the two examinations. Cerebellar, medulla oblongata, and cervical spinal cord atrophy can
also be observed
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In the previously published TWNK-associated Perrault
patients, brain MRI found normal status in two cases,
non-specific white matter changes in two patients, and
cerebellar atrophy in other cases. In our patient, medulla
oblongata and cervical spinal cord atrophy, moderate cor-
tical atrophy, and hyperintense signs in the cerebellum
were detected. Hyperintense signs in the cerebellum is an
interesting novelty, it had not been described previously.
The atrophy usually reported in Perrault syndrome typic-
ally affected the cerebellum, not the medulla oblongata
and cervical spinal cord like in our case [3, 12, 14]. In two
previous cases without MRI brain abnormalities, cerebral
SPECT (single photon emission computed tomography)
scan could identify cerebellar hypoperfusion [12]. We do
not have information about EEG examinations in other
TWNK-dependent Perrault syndrome cases, but upon
examination, we could detect mild cortical dysfunction.
The presence of the mixed type sensory neuropathy is in
line with the previous findings. In both the muscle and
the sural nerve tissue, slight mitochondrial abnormalities
were present.
Perrault syndrome is still not fully characterized genet-
ically, and, in several cases, the genetic diagnosis is miss-
ing. By our report, we could add a novel mutation
(c.1358G > A) to the spectrum and confirm a recently
described disease-causing variation (c.1196A > G). In the
future, it will be necessary to continue to identify new
mutations, to find new patients, and to follow-up the
Fig. 4 a Sanger traces of the identified mutations b pedigree information with segregation information. The mother is heterozygous for
c.1196A > G, the father is heterozygous for c.1358A > G, and one female sibling is heterozygous for c.1196A > G, the other healthy sibling does
not carry any of the examined mutations
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existing patients to better characterize the phenotype
and be able to provide the best possible care by under-
standing the disease.
Our observation confirms the reports that Twinkle pro-
tein dysfunction is associated with Perrault syndrome.
Our results demonstrate that TWNK-associated Perrault
syndrome has a much broader phenotype than originally
was published. The coexistence of severe hypoacusis, spas-
tic limb weakness, ataxia, polyneuropathy, gonadal dys-
genesis, and hyperintense signals in the cerebellum, and
the presence of the mtDNA multiple deletion could indi-
cate the impairment of the TWNK gene. This is the first
report about pyramidal tract involvement and cerebellar
hyperintense MRI signs associated to TWNK-related Per-
rault syndrome. Our observations confirm the pathogen-
icity of the c.1196A >G mutation and identify a new
pathogenic mutation as c.1358G > A.
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